Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - Anti-Cancer Agents

Volume 1

eBook: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library License: US $356
ISSN: 2215-0803 (Online)
ISBN: 978-1-60805-799-3 (Print)
ISBN: 978-1-60805-798-6 (Online)
Year of Publication: 2014
DOI: 10.2174/97816080579861130101

Introduction

Frontiers in Clinical Drug Research - Anti-Cancer Agents should prove to be a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field. The chapters in this volume have been written by leading experts from the field.

The contents of this book include new approaches to cancer therapy, treatment of metastatic non-small cell lung cancer with epidermal growth factor receptor-tyrosine kinase inhibitors, targeting key signaling pathways in pediatric brain tumors, current status of cladribine in lymphoid and myeloid malignancies, natural anti-cancer products and the mechanisms of telomere and telomerase regulation in hematologic malignancies.

The eBook series is essential to all scientists involved in clinical drug research who wish to keep abreast of rapid and important developments in the field. The readers will find these reviews valuable and will certainly trigger further research in the pharmaceutical development of anti-cancer agents.

Contributors

Editor(s):
Atta-ur-Rahman FRS
Kings College, University of Cambridge
Honorary Life Fellow
Cambridge
UK




Contributor(s):
Fernanda I. Arnaldez
National Institutes of Health/National Cancer Institute/Pediatric Oncology Branch
Center for Cancer Research, Building 10 CRC Room 1-3816
Bethesda
MD, 20892
USA


JingBo Wu
Department of Oncology
The Affiliated Hospital of Luzhou Medical College
Luzhou Medical College
Luzhou
China


Katherine E. Warren
National Institutes of Health/National Cancer Institute/Pediatric Oncology Branch
Center for Cancer Research, Building 10 CRC Room 1-3816
Bethesda
MD, 20892
USA


Kiyotaka Kawauchi
Tokyo Women's Medical University, Medical Center East, Department of Medicine
2-1-10 Nishiogu Arakawa-ku
Tokyo, 116-8567
Japan
/
Nishiogu Clinic, 6-15-5 Nishiogu Arakawa-ku
2-1-10 Nishiogu Arakawa-ku
Tokyo, 116-0011
Japan


LingLin Yang
Department of Oncology
The Affiliated Hospital of Luzhou Medical College
Luzhou Medical College
Luzhou,
China


Masaharu Akiyama
The Jikei University School of Medicine
Department of Pediatrics and Division of Molecular Genetics
Institute of DNA Medicine, 3-25-8 Nishishinbashi Minatoku,
Tokyo, 105-8461
Japan


Osamu Yamada
Teikyo Heisei University, Division of Human Health Care
4-21-2 Nakano, Nakano-ku
Tokyo
Japan


Pawel Robak
Department of Experimental Hematology
Medical University of Lodz
93-510 Łódź
Ciolkowskiego 2
Poland


Reto A. Schwendener
Institute of Molecular Cancer Research
University of Zurich
Zurich
Switzerland


ShaoZhi Fu
Department of Oncology
The Affiliated Hospital of Luzhou Medical College
Luzhou Medical College
Luzhou
China


Sibel Mete
Institute of Molecular Cancer Research
University of Zurich
Zurich,
Switzerland


Tadeusz Robak
Department of Hematology
Medical University of Lodz
93-510 Łódź
Ciolkowskiego 2
Poland


Vera Hirsh
Chief, Hematology-Oncology Services
Santa Cabrini Hospital

/
Associate Physician, Oncology Services
Royal Victoria Hospital and Montréal General Hospital

/
Associate Professor, Department of Oncology
Faculty of Medicine, McGill University
Montréal
Québec
Canada




RELATED BOOKS

.Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine.
.Current Advances in Breast Cancer Research: A Molecular Approach.
.Avastin and Malignant Gliomas .
.Cutting Edge Therapies for Cancer in the 21 Century.